Dr Reddy's Q3 net profit dips 29% at Rs 363 cr

New Delhi: Drug major Dr Reddy's Laboratories today reported 29.17 percent decline in its consolidated net profit at Rs 363.31 crore for the third quarter ended 31 December 2012.

The company had posted a net profit of Rs 512.96 crore in the same period of previous fiscal, Dr Reddy's Laboratories said in a filing to the BSE.

Trimmed profit. Reuters

Trimmed profit. Reuters

The Hyderabad-based firm's consolidated net income from sales and services, however, rose to Rs 2,865.16 crore in the third quarter, compared to Rs 2,769.19 crore in the same period of 2011-12 fiscal.

On a standalone basis, the company's net profit rose over three-fold to Rs 346.64 crore for the third quarter, against Rs 108.03 crore in the same period of previous fiscal.

Shares of Dr Reddy's Laboratories were trading at Rs 1,884.50 apiece on the BSE in late afternoon trade, down 1.11 percent from its previous close.

PTI


Updated Date: Dec 20, 2014 16:55 PM

Also Watch

Watch: Firstpost test rides the new Thunderbird 500X in Goa and walks you through the Royal Enfield Garage Cafe
  • Tuesday, April 17, 2018 Varun Dhawan on Shoojit Sircar's October, 5-star reviews and working with Anushka Sharma in Sui Dhaaga
  • Saturday, April 14, 2018 Ambedkar Jayanti: Re-visiting Babasaheb's ideals exposes fake Dalit politics of Rahul Gandhi and Congress
  • Monday, April 9, 2018 48 hours with Huawei P20 Pro: Triple camera offering is set to redefine smartphone imaging
  • Monday, April 16, 2018 Rajyavardhan Singh Rathore interview: Sports can't be anyone's fiefdom, we need an ecosystem to nurture raw talent

Also See